Peptides in the UK — legal & regulatory status (2026)
What you can legally buy, possess, and take in the UK as of 2026. Prescription pathways, research-chemical grey zones, and MHRA policy.
The short version
- Licensed peptides (semaglutide, tirzepatide, liraglutide): prescription-only medicines. Legal to possess and use with a valid UK prescription. Increasing access via private telehealth and — since 2025 — NHS weight-management services.
- Unlicensed peptides (BPC-157, TB-500, CJC-1295, ipamorelin, MOTS-c, epitalon): not MHRA-approved. Typically sold as "research chemicals" with a "not for human consumption" framing. Personal possession is generally not criminalised, but sale for human use is.
- Controlled peptides: a small subset falls under the Misuse of Drugs Act or Psychoactive Substances Act 2016 on a case-by-case basis.
The MHRA position
The Medicines and Healthcare products Regulatory Agency regulates marketing authorisations. A peptide without a UK marketing authorisation cannot be sold or supplied as a medicine. Research-chemical vendors navigate this by framing products as laboratory reagents.
The Psychoactive Substances Act
The PSA 2016 bans "psychoactive substances" not otherwise controlled. Most peripherally-acting peptides (tissue repair, metabolic) are not psychoactive and fall outside PSA scope. Some CNS-active peptides (Selank, Semax, some nootropics) sit in a greyer area.
Athlete considerations
The World Anti-Doping Agency (WADA) prohibits many peptides at all times, including BPC-157, TB-500, and all GH secretagogues. If you compete under any WADA-aligned body, the compounds in this site's stacks will cause a failed drug test.
Regulatory frameworks change. Check current MHRA and Home Office guidance, and speak to a solicitor or clinician about your specific situation.